Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders
Miroslav Adžić, Zeljka Brkic, S. Bulajić, et al.
Drug Development Research (2016) Vol. 77, Iss. 7, pp. 400-406
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Post-stroke depression: Mechanisms and pharmacological treatment
R. F. Villa, Federica Ferrari, Antonio Moretti
Pharmacology & Therapeutics (2017) Vol. 184, pp. 131-144
Closed Access | Times Cited: 412
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Josh Allen, Raquel Romay-Tallón, Kyle J. Brymer, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 276
Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder
Daniel Lindqvist, Owen M. Wolkowitz, Martin Picard, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 7, pp. 1557-1564
Open Access | Times Cited: 169
Stress and Psychiatric Disorders: The Role of Mitochondria
Teresa E. Daniels, Elizabeth M. Olsen, Audrey R. Tyrka
Annual Review of Clinical Psychology (2020) Vol. 16, Iss. 1, pp. 165-186
Open Access | Times Cited: 96
The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
Anna Giménez‐Palomo, Seetal Dodd, Gerard Anmella, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 93
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Luodan Yang, Hannah Youngblood, Chongyun Wu, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 92
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Carsten Culmsee, Susanne Michels, Stefanie Scheu, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 86
Connecting Dots between Mitochondrial Dysfunction and Depression
Mehtab Khan, Yann Baussan, Étienne Hébert-Chatelain
Biomolecules (2023) Vol. 13, Iss. 4, pp. 695-695
Open Access | Times Cited: 27
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
Huiyang Liu, Xiaomei Zhang, Peng Shi, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature
Zsolt Kovács, Dominic P. D’Agostino, David M. Diamond, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 73
Serotonin regulation of mitochondria in kidney diseases
Kevin Hurtado, Natalie E. Scholpa, Jennifer G Schnellmann, et al.
Pharmacological Research (2024) Vol. 203, pp. 107154-107154
Open Access | Times Cited: 7
IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids
Elisa Martín‐Montañez, Carmelo Millón, Federica Boraldi, et al.
Redox Biology (2017) Vol. 13, pp. 69-81
Open Access | Times Cited: 54
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine
R. F. Villa, Federica Ferrari, Laura Bagini, et al.
Neuropharmacology (2017) Vol. 121, pp. 30-38
Open Access | Times Cited: 51
Mitochondria dysfunction and bipolar disorder: From pathology to therapy
Xin-Jieh Lam, Bingzhe Xu, Pei-Ling Yeo, et al.
IBRO Neuroscience Reports (2023) Vol. 14, pp. 407-418
Open Access | Times Cited: 13
Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression
Yan Zhao, Yulong Chen, Chi-Hua Guo, et al.
Theranostics (2024) Vol. 14, Iss. 9, pp. 3653-3673
Open Access | Times Cited: 4
Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence
Brandi Rollins, Ling Morgan, Brooke E. Hjelm, et al.
Complex Psychiatry (2017) Vol. 3, Iss. 3, pp. 157-169
Open Access | Times Cited: 43
A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network
M.T. Ciubuc-Batcu, Nicolas J. C. Stapelberg, John P. Headrick, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166920-166920
Open Access | Times Cited: 11
Psychiatric drugs impact mitochondrial function in brain and other tissues
Shawna T. Chan, Michael J. McCarthy, Marquis P. Vawter
Schizophrenia Research (2019) Vol. 217, pp. 136-147
Open Access | Times Cited: 34
Molecular correlates of mitochondrial dysfunctions in major depression: Evidence from clinical and rodent studies
Virginie Rappeneau, Lars Wilmes, Chadi Touma
Molecular and Cellular Neuroscience (2020) Vol. 109, pp. 103555-103555
Closed Access | Times Cited: 31
Brain cytochrome‐c‐oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS
Lisa Holper, Martin J. Lan, Patrick J. Brown, et al.
Depression and Anxiety (2019) Vol. 36, Iss. 8, pp. 766-779
Open Access | Times Cited: 30
Effect of neuropsychiatric medications on mitochondrial function: For better or for worse
Tim L. Emmerzaal, Gerben Nijkamp, Marin Veldić, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 555-571
Open Access | Times Cited: 24
DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?
Piotr Czarny, Katarzyna Białek, Sylwia Ziółkowska, et al.
Mutagenesis (2019)
Closed Access | Times Cited: 27
Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling
Nirmala Arul Rayan, Vibhor Kumar, Jonathan Aow, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4510-4525
Open Access | Times Cited: 15
New insights into the intracellular distribution pattern of cationic amphiphilic drugs
Magdalena Vater, Leonhard Möckl, Vanessa Gormanns, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 27
Effects of resveratrol on the levels of ATP, 5-HT and GAP-43 in the hippocampus of mice exposed to chronic unpredictable mild stress
Ji-Duo Shen, Yuewen Zhang, Baoying Wang, et al.
Neuroscience Letters (2020) Vol. 735, pp. 135232-135232
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top